Popular Articles

Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments At Top Dutch Oncology Center
Doctors in the Netherlands have developed new ways to perform radiosurgery on benign acoustic tumors using fast and precise RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). This is among the findings in several papers published by the team at VU University Medical Center in Amsterdam.
generic viagra online
Clear Difference In Quality, Type Of Lung Cancer Info Available In US And Japan
A study published in the July 2009 issue of the Journal of Thoracic Oncology revealed that internet-based lung cancer information was of a higher quality in the United States (US) than in Japan. Dr. Yasushi Goto of the National Cancer Center Hospital in Tokyo and his team of researchers from both the US and Japan evaluated 150 Web sites and determined noticeable differences in the quality and type of information on lung cancer available over the internet in the two countries.
News of the day
The Right Cardiovascular Care For The Right Patient At The Right Time: ACC Positions Quality At Center Of Health-Care Reform
The American College of Cardiology (ACC) - long at the forefront of quality initiatives - is taking a leading role in health care reform. In partnership with patients, lawmakers and payers, the ACC is setting a new standard for health care delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.
Endocrinology

Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes?

A team of Canadian scientists have discovered that naringenin, a flavonoid found in citrus fruit, and especially grapefruit, makes the liver burn fat instead of storing it after a meal. (This chemical compound also gives grapefruit its bitter taste.) Potentially, without having to change diets or cut out particular foods, a dose of naringenin could prevent weight gain and even help to lose it. Two groups of mice were both fed the equivalent of a Western diet to speed up their "metabolic syndrome" - the process which leads to Type 2 diabetes in humans. "Reprogrammed" liver The food given to one of the groups was treated with naringenin. The non-naringenin mice became obese and developed the metabolic syndrome which saw their cholesterol rise and their bodies become resistant to insulin. The mice given naringenin, however, had none of these problems. Any rise in cholesterol was corrected by the naringenin which also "reprogrammed" the liver to burn up fat rather than store it. In the long-term the Canadian team behind the tests believe the compound could help fight diabetes because the process also helped balance insulin and glucose levels. "What was unique about the study was that the effects were independent of caloric intake, meaning the mice ate exactly the same amount of food and the same amount of fat," explained lead researcher Professor Murray Huff. "There was no suppression of appetite or decreased food intake, which are often the basis of strategies to reduce weight gain and its metabolic consequences," he said. Safe supplement needed However, Diabetes Research Manager Victoria King warned: "The results of these experiments carried out in mice involve much higher doses of naringenin than those found naturally in grapefruit. "A concentrated and safe supplement would therefore need to be developed for humans before it could even be shown that these effects seen in mice are reproducible in humans and that they are applicable to the treatment of Type 2 diabetes. "Simple lifestyle changes such as maintaining a healthy weight, eating a balanced diet and being more physically active can help to reduce your risk of developing Type 2 diabetes and can also help people diagnosed with the condition to manage it more effectively." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):